OxyContin manufacturer Purdue Pharma LP generated more than $10 billion since 2008 for the Sackler family members who own the company, according to a report that will influence the debate among state and local governments over how much of that money should be returned.

The report, written by Purdue adviser AlixPartners LLP and filed in a New York bankruptcy court Monday, is the most thorough accounting yet of dividends collected by the controlling Sackler family during years in which opioid consumption grew into a nationwide…

Read More